BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2022 7:20:14 AM | Browse: 332 | Download: 803
 |
Received |
|
2022-10-07 16:01 |
|
Peer-Review Started |
|
2022-10-07 16:03 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-10-27 00:53 |
|
Revised |
|
2022-11-10 03:24 |
|
Second Decision |
|
2022-11-24 03:06 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-11-24 06:44 |
|
Articles in Press |
|
2022-11-24 06:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-11-30 15:55 |
|
Publish the Manuscript Online |
|
2022-12-14 07:20 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemical Research Methods |
| Manuscript Type |
Case Report |
| Article Title |
Systemic combined with intravitreal methotrexate for relentless placoid chorioretinitis: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lan Luo, Wei-Bin Chen, Ming-Wei Zhao and Heng Miao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China (General Program) |
81800847 |
| the tenth "Academic Star" of Peking University People's Hospital |
RS2018-05 |
|
| Corresponding Author |
Heng Miao, MD, Doctor, Doctor, Department of Ophthalmology & Clinical Center of Optometry, Peking University People’s Hospital, Xizhimen South Street 11, Xi Cheng District, Beijing 100044, China. sawyer_young@sina.com |
| Key Words |
Immunosuppression; Intravitreal; Methotrexate; Relentless placoid chorioretinitis; Systemic; Case report |
| Core Tip |
Relentless placoid chorioretinitis is a bilateral disease in nature and refractory to corticosteroid monotherapy, which warrants the importance of systemic immunosuppressants given upon diagnosis. Intravitreal methotrexate should also be considered as part of the initial therapy for macula-threatening cases in order to halt progression immediately and preserve visual function. |
| Publish Date |
2022-12-14 07:20 |
| Citation |
Luo L, Chen WB, Zhao MW, Miao H. Systemic combined with intravitreal methotrexate for relentless placoid chorioretinitis: A case report. World J Clin Cases 2022; 10(35): 13115-13121 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i35/13115.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i35.13115 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
